Retriev Technologies (United States)

Recent papers from Retriev Technologies (United States)

1. New widow spider record of Latrodectus dahli Levi (Araneae: Theridiidae) extends known range in Northern Saudi ArabiaBiodiversity · 2026
2. New Approach Methods in Genetic ToxicologyEnvironmental and Molecular Mutagenesis · 2026
3. Investigation of mode-of-action and human relevance of cumene-induced mouse liver tumorsJournal of Toxicology and Environmental Health Part B · 2026
4. Protein Large Language Models Can Predict Flavivirus Protease Target SpecificityACS Omega · 2026
5. A critical review of styrene and styrene-7,8-oxide genotoxicity literature: an updateJournal of Environmental Science and Health Part C · 2026
6. Pathogenic PF4/Polyvinylsulfonate ELISA-negative Antibodies in HIT2025
7. A Comprehensive Toxicological Safety Evaluation of Anaerostipes caccae2025
8. Valifenalate-induced non-adverse thyroid changes via adaptive induction of uridine 5′-diphospho-glucuronosyltransferase (UGT) in the liver of dogs and rats but not humansToxicology and Applied Pharmacology · 2024
9. Interlaboratory validation of the ToxTracker assay: An in vitro reporter assay for mechanistic genotoxicity assessmentEnvironmental and Molecular Mutagenesis · 2024
10. Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approachJournal of Biomedical Informatics · 2023
11. Examining the role of visible light in photocarcinogenesis – Lessons from the pastJournal of Photochemistry and Photobiology · 2023
12. Data from Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity2023
13. Data from Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity2023
14. Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung CancerCancers · 2022
15. Retroviral Replicating Vector Toca 511 (vocimagene amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer2022
16. Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancerExpert Opinion on Biological Therapy · 2021
17. Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FCNeuro-Oncology · 2018
18. A toxicological review of the ethylene glycol series: Commonalities and differences in toxicity and modes of actionToxicology Letters · 2017
19. Non a Priori Automatic Discovery of 3D Chemical Patterns: Application to MutagenicityMolecular Informatics · 2017
20. Preferential expression of scores of functionally and evolutionarily diverse DNA and RNA-binding proteins during Oxytricha trifallax macronuclear developmentPLoS ONE · 2017